Skip to main content
Equibles
CLDI logo

CLDI · Calidi Biotherapeutics, Inc.

Track CLDI — free

Use CLDI with AI

Ask our own analyst here, or connect this data to the AI you already use.

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$1.35 +0.03 (+1.89%)
Rebalance outlook locked
Going-concern doubt — flagged Aug 13, 2026

Substantial doubt about the company's ability to continue as a going concern.

“The Company estimates that based on the Company's liquidity resources, there is substantial doubt about the Company's ability to continue as a going concern within 12 months from the date of issuance of these unaudited condensed consolidated financial statements.”
View the 10-Q filed Aug 13, 2026
Market Cap
$3.41M
Shares
2.58M

Daily short-sale volume published by FINRA from its trade-reporting facilities. It measures how many shares were sold short each day as a share of total volume — a daily flow, not the total outstanding short position.

1M 3M 6M 1Y 5Y All
Dimensions
  • Add to chart

    • Short Volume

    Date Short Volume Short Exempt Total Volume Short %
    2026-08-31 3,062 0 14,342 21.4%
    2026-08-28 7,150 0 19,566 36.5%
    2026-08-27 17,759 0 64,202 27.7%
    2026-08-26 8,086 0 22,611 35.8%
    2026-08-25 3,502 0 17,308 20.2%
    2026-08-24 6,116 0 13,968 43.8%
    2026-08-21 18,083 0 30,272 59.7%
    2026-08-20 10,045 0 28,384 35.4%
    2026-08-19 17,441 0 67,519 25.8%
    2026-08-18 14,651 2,507 64,134 22.8%
    2026-08-17 61,731 13,883 147,392 41.9%
    2026-08-14 49,716 0 78,289 63.5%
    2026-08-13 42,194 0 64,854 65.1%
    2026-08-12 22,256 400 40,508 54.9%
    2026-08-11 95,600 1,400 127,053 75.2%
    2026-08-10 61,626 3,477 100,033 61.6%
    2026-08-07 44,738 1,007 92,550 48.3%
    2026-08-06 71,795 12,458 116,520 61.6%
    2026-08-05 19,403 1,536 52,192 37.2%
    2026-08-04 62,125 0 131,179 47.4%
    2026-08-03 48,191 0 82,244 58.6%
    2026-07-31 163,320 0 282,228 57.9%
    2026-07-29 10,134 366 68,104 14.9%
    2026-07-28 37,208 0 64,928 57.3%
    2026-07-27 140,178 493 271,624 51.6%
    2026-07-24 152,173 600 294,358 51.7%
    2026-07-23 105,468 0 222,896 47.3%
    2026-07-22 72,592 9,796 109,863 66.1%
    2026-07-21 44,594 2,877 94,487 47.2%
    2026-07-20 30,124 69 52,423 57.5%
    2026-07-17 11,508 0 54,856 21.0%
    2026-07-16 4,670 0 27,414 17.0%
    2026-07-15 5,505 205 62,335 8.8%
    2026-07-14 35,973 7,228 72,160 49.9%
    2026-07-13 48,968 564 86,360 56.7%
    2026-07-10 19,075 6 36,554 52.2%
    2026-07-09 20,809 0 33,118 62.8%
    2026-07-08 17,517 3,364 26,784 65.4%
    2026-07-07 27,327 658 60,763 45.0%
    2026-07-06 33,320 0 59,499 56.0%
    2026-07-02 32,593 0 101,590 32.1%
    2026-07-01 30,077 0 73,895 40.7%
    2026-06-30 78,360 2,828 128,835 60.8%
    2026-06-29 98,602 2,594 156,785 62.9%
    2026-06-26 442,710 1,804 738,823 59.9%
    2026-06-25 31,366 286 56,217 55.8%
    2026-06-24 89,546 52 148,572 60.3%
    2026-06-23 19,088 37 34,627 55.1%
    2026-06-22 38,502 0 67,158 57.3%
    2026-06-18 133,238 827 210,155 63.4%
    Showing 1–50 of 63 days
    Key facts CIK 1855485 CUSIP 320703408 13F (30d) 15 filings 15 filers Visit website Investor relations

    Report a Problem

    Category
    Description
    Email (optional, for follow-up)